Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma

ADCLEC.syn1 and CD33-CARS in humanised acute myeloid leukaemia models shows promising efficacy

Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard regimens

A randomised trial of the FLT3 inhibitor gilteritinib as post-transplant maintenance for FLT3-ITD AML

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer

Advancing breast cancer treatment in Uganda by improving molecular testing

Somatic mutation profile of breast cancer in Uganda

Optimising cervical cancer care in Nigeria

Tackling low-volumes of clinical trials in Africa